GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
Open Access
- 3 January 2011
- journal article
- Published by Hematology Section, Dept. of Radiological Science and Hematology, Catholic University, Rome, Italy in Mediterranean Journal of Hematology and Infectious Diseases
- Vol. 3 (1), e2011019
- https://doi.org/10.4084/mjhid.2011.019
Abstract
Therapy-related myeloid neoplasm (t-MN) is a distinctive clinical syndrome occurring after exposure to chemotherapy or radiotherapy. t-MN arises in most cases from a multipotential hematopoietic stem cell or, less commonly, in a lineage committed progenitor cell. The prognosis for patients with t-MN is poor, as current forms of therapy are largely ineffective. Cytogenetic analysis, molecular analysis and gene expression profiling analysis of t-MN has revealed that there are distinct subtypes of the disease; however, our understanding of the genetic basis of t-MN is incomplete. Elucidating the genetic pathways and molecular networks that are perturbed in t-MNs, may facilitate the identification of therapeutic targets that can be exploited for the development of urgently-needed targeted therapies.Keywords
This publication has 46 references indexed in Scilit:
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changesBlood, 2009
- Integrated Genomic Analysis Implicates Haploinsufficiency of Multiple Chromosome 5q31.2 Genes in De Novo Myelodysplastic Syndromes PathogenesisPLOS ONE, 2009
- Therapy-Related Myeloid LeukemiaSeminars in Oncology, 2008
- Mechanisms of therapy-related carcinogenesisNature Reviews Cancer, 2005
- Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago seriesPublished by American Society of Hematology ,2003
- Narrowing and genomic annotation of the commonly deleted region of the 5q− syndromeBlood, 2002
- Transcript Map and Comparative Analysis of the 1.5-Mb Commonly Deleted Segment of Human 5q31 in Malignant Myeloid Diseases with a del(5q)Genomics, 2001
- Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1–1.5 Mb and preparation of a PAC-based physical mapProceedings of the National Academy of Sciences of the United States of America, 1997
- Physical mapping of the minimal region of loss in 5q- chromosome.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II.1991